These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21779876)

  • 1. Prognostic impact of B-cell density in cutaneous melanoma.
    Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
    Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
    Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
    Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
    Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
    Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma.
    Ladányi A; Somlai B; Gilde K; Fejös Z; Gaudi I; Tímár J
    Clin Cancer Res; 2004 Jan; 10(2):521-30. PubMed ID: 14760073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
    Kakavand H; Vilain RE; Wilmott JS; Burke H; Yearley JH; Thompson JF; Hersey P; Long GV; Scolyer RA
    Mod Pathol; 2015 Dec; 28(12):1535-44. PubMed ID: 26403784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cells in primary melanoma. Prognostic significance and possible role of IgA.
    Bosisio FM; Wilmott JS; Volders N; Mercier M; Wouters J; Stas M; Blokx WA; Massi D; Thompson JF; Scolyer RA; van Baren N; van den Oord JJ
    Mod Pathol; 2016 Apr; 29(4):347-58. PubMed ID: 26867783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma.
    Kiss J; Tímár J; Somlai B; Gilde K; Fejôs Z; Gaudi I; Ladányi A
    Pathol Oncol Res; 2007; 13(1):21-31. PubMed ID: 17387385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma.
    Lynch KT; Young SJ; Meneveau MO; Wages NA; Engelhard VH; Slingluff CL; Mauldin IS
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34103353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of intratumoral and peritumoral lymphocytes and lymphocyte score based on the histologic subtypes of cutaneous melanoma.
    Park CK; Kim SK
    Oncotarget; 2017 Feb; 8(9):14759-14769. PubMed ID: 28107203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of tumor-infiltrating immune cells in melanoma].
    Ladányi A
    Magy Onkol; 2013 Jun; 57(2):85-95. PubMed ID: 23795353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.
    Erdag G; Schaefer JT; Smolkin ME; Deacon DH; Shea SM; Dengel LT; Patterson JW; Slingluff CL
    Cancer Res; 2012 Mar; 72(5):1070-80. PubMed ID: 22266112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
    Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
    Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas.
    Chłopik A; Selim MA; Peng Y; Wu CL; Tell-Marti G; Paral KM; Shalin SC; Kraft S; Hsu CK; Shea CR; Puig S; Fernandez-Figueras MT; Biernat W; Ryś J; Marszalek A; Hoang MP
    Hum Pathol; 2018 Mar; 73():176-183. PubMed ID: 29307625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma.
    Ladányi A; Mohos A; Somlai B; Liszkay G; Gilde K; Fejos Z; Gaudi I; Tímár J
    Pathol Oncol Res; 2010 Sep; 16(3):303-9. PubMed ID: 20306313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients.
    De Logu F; Galli F; Nassini R; Ugolini F; Simi S; Cossa M; Miracco C; Gianatti A; De Giorgi V; Rulli E; Cossu A; Massi D; Mandalà M
    Cells; 2021 Feb; 10(2):. PubMed ID: 33671367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
    Stenström J; Hedenfalk I; Hagerling C
    Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes.
    Lee WJ; Lee YJ; Choi ME; Yun KA; Won CH; Lee MW; Choi JH; Chang SE
    J Am Acad Dermatol; 2019 Jul; 81(1):219-227. PubMed ID: 30880064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paucity of tumor-infiltrating lymphocytes is an unfavorable prognosticator and predicts lymph node metastases in cutaneous melanoma patients.
    Donizy P; Kaczorowski M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Anticancer Res; 2015 Jan; 35(1):351-8. PubMed ID: 25550571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
    Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
    J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.